An antipsychotic turns dopamine signaling down. A stimulant turns it up. Both can help the right person, because dopamine is not one dial.
Part 1 of the Brain Chemistry series. New here? Start with Your Brain Is Not a Gas Tank, the short orientation that explains the four questions every article in this series answers.
What to know
- Dopamine is not the pleasure chemical. It helps the brain learn, choose actions, control movement, hold attention, and manage a hormone called prolactin.
- Five different receptors receive dopamine. A medicine that reaches one of them in the movement circuit does something different from the same medicine reaching the attention circuit.
- Antipsychotics act mostly at the D2 receptor. Some block it. At least one only partly switches it on. Stimulants work somewhere else entirely, at the proteins that clean dopamine up.
- No blood test, urine test, or gene test can measure the dopamine in your brain circuits. Panels that claim to do this are selling something.
- A side effect does not prove a medicine is working, and improvement does not prove you were low to begin with.
The short answer
Dopamine is a chemical messenger. Nerve cells release it, and it lands on receptors that change what the receiving cell does next.
There are five of these receptors. D1 and D5 belong to one family. D2, D3, and D4 belong to another. A separate protein called the dopamine transporter, or DAT, pulls dopamine back out of the space between cells when the signal is over.
That last detail is the key to the whole puzzle. Antipsychotics and stimulants do not act on the same part of the system.
Most antipsychotics work at the D2 receptor. Lurasidone blocks it. Aripiprazole partly activates it, which is a different action with a different feel. Methylphenidate does not touch D2 at all. It blocks the transporter, so dopamine stays in the gap longer. Amphetamine goes further and pushes dopamine out of the cell.
So “raises dopamine” and “blocks dopamine” are not opposites in the way they sound. They are different jobs, in different circuits, on different clocks.12
Dopamine has at least five jobs that matter to psychiatric care.
Movement. A pathway running from the midbrain to a region called the striatum helps you start, size, and stop a movement. Parkinson disease involves the loss of the cells in this pathway. When a medicine blocks D2 receptors here, some people develop stiffness, tremor, or a restless inability to sit still called akathisia.3
Wanting, more than liking. Dopamine helps update what your brain expects and gives certain cues a pull. Researchers call that pull incentive salience. It is closer to wanting something than to enjoying it. Pleasure itself runs on wider machinery, including the body’s own opioid and cannabinoid systems.4
Attention and working memory. Dopamine and norepinephrine together help tune focus and hold information in mind. Both too little and too much signaling can hurt performance on a given task. That is not the same as a brain-wide shortage.5
Salience in psychosis. Brain scans of groups of people with psychosis find higher dopamine production, on average, in specific parts of the striatum. A large analysis found the difference was strongest in the associative and sensorimotor regions, not the limbic region that older teaching emphasized.6 That is a finding about groups. It cannot diagnose one person.
Prolactin. Dopamine from the hypothalamus normally holds back a hormone called prolactin. Block those receptors and prolactin can rise, which for some people means changes to periods, sexual function, fertility, or bone health.7
One messenger. Five jobs. This is why the same medicine can help in one place and cause a problem in another.
Meet the five receptors
| Receptor or target | What it does, where it matters, and why you might care |
|---|---|
| D1 and D5 | What it does: Usually turn cell signaling up. Where it matters: Striatum and cortex. Why you might care: Movement, learning, working memory. No routine psychiatric medicine targets these on purpose. |
| D2 | What it does: Usually turns signaling down. Also gives dopamine cells feedback about their own output. Where it matters: Striatum, pituitary, midbrain, cortex. Why you might care: The main antipsychotic target. Also where movement and prolactin effects come from. |
| D3 and D4 | What it does: Similar signaling to D2. Where it matters: Limbic and cortical regions. Why you might care: Heavily researched for motivation and thinking. No routine medicine selectively targets them. |
| Dopamine transporter (DAT) | What it does: Pulls dopamine back into the nerve ending. Where it matters: Especially the striatum. Why you might care: Block it and dopamine stays active longer while the drug is present. This is methylphenidate’s target. |
| VMAT2 | What it does: Loads dopamine into storage packets inside the cell. Where it matters: Nerve endings. Why you might care: Blocking it can reduce some involuntary movements. This is how valbenazine treats tardive dyskinesia. |
Location changes everything. A D2 receptor sitting on a dopamine cell tells that cell to release less. A D2 receptor on a target cell changes what the target cell does. A D2 receptor in the pituitary controls prolactin. Same receptor name, three different consequences.8
Why brain scans do not settle it
A PET scan can estimate how many available D2 receptors a drug is sitting on. That number is called occupancy.
Occupancy is not the same as benefit. The scan cannot tell whether the drug is blocking the receptor or partly switching it on, and it cannot predict whether the person will feel better. Two medicines at the same occupancy can produce very different results.93
This is worth knowing because occupancy numbers get quoted as if they settle the question of whether a dose is right. They do not.
What each medicine actually touches
| Medicine | What it does directly, used for, and main tradeoffs |
|---|---|
| Lurasidone | What it does directly: Blocks D2 and a serotonin receptor called 5-HT2A. Used for: Schizophrenia; depression in bipolar disorder. Main tradeoffs: Movement effects, sedation, metabolic changes, prolactin, interactions with certain other drugs. |
| Aripiprazole | What it does directly: Partly activates D2 rather than blocking it fully. Used for: Varies by product. Main tradeoffs: Restlessness, compulsive behaviors, movement and metabolic effects, blood pressure changes. |
| Milsaperidone (Bysanti) | What it does directly: Blocks D2 and serotonin receptors; converts back and forth with a related drug in the body. Used for: Schizophrenia; manic or mixed episodes in adults. Main tradeoffs: Heart rhythm, dizziness on standing, movement and metabolic effects. Approved February 2026. |
| Methylphenidate | What it does directly: Blocks the dopamine transporter and the norepinephrine transporter. Used for: ADHD; narcolepsy, depending on product. Main tradeoffs: Appetite, sleep, pulse, blood pressure, growth in children; boxed warning for misuse, abuse, and addiction. |
| Amphetamine medicines | What it does directly: Enter the nerve ending and push dopamine and norepinephrine out. Used for: ADHD; some products treat binge-eating disorder. Main tradeoffs: Same as above, including the boxed warning; misuse can cause overdose and death. |
| Valbenazine | What it does directly: Blocks VMAT2, reducing dopamine loading into storage packets. Used for: Tardive dyskinesia; chorea in Huntington disease. Main tradeoffs: Sleepiness, parkinsonism, heart rhythm. Boxed warning for depression and suicidality in Huntington disease. |
| Bupropion | What it does directly: Affects norepinephrine and dopamine reuptake, though one human scan study found it occupies very little of the transporter. Used for: Depression; preventing seasonal depression. Main tradeoffs: Seizure risk, blood pressure, activation, interactions. |
These are not interchangeable. Approved ages, forms, and uses differ by product. Levodopa, which the body converts into dopamine, is a Parkinson disease treatment and is not used to top up dopamine in depression, ADHD, or psychosis.10
Why benefit and side effects arrive together
Follow the chain for an antipsychotic:
The drug reaches D2 receptors. Signaling changes. In one circuit that may quiet the intensity of psychosis. In the movement circuit the same action can cause stiffness or restlessness. In the pituitary it can raise prolactin. Over weeks, the brain adapts to all of it.
Now follow a stimulant:
The drug blocks transporters. Dopamine and norepinephrine linger. Attention may sharpen. Appetite may drop, sleep may shorten, and pulse may rise, because those transporters exist outside the attention circuit too.
One target. Several destinations. That is the whole explanation, and it is why “this medicine has side effects” and “this medicine is working” are two separate questions that deserve two separate answers.
Can dopamine be measured?
Not in the way people hope.
Research scans can estimate receptor availability, how much of a target a drug occupies, how much dopamine a region can make, or how much is released after a challenge. These are narrow research measures. None is a routine test for depression, ADHD, psychosis, or choosing a medicine.
Transporter imaging has a real clinical use in certain movement disorder questions. It is not an ADHD test.
Blood and urine mostly reflect what the body is doing outside the brain, plus the effects of collection, diet, and medicines. Spinal fluid can help in rare inherited conditions. Commercial neurotransmitter panels sold for common symptoms do not measure your brain.11
Pharmacogenetic testing is a different thing again. It can answer selected questions about how fast you process a drug. Milsaperidone, for example, has dosing boundaries tied to a liver enzyme called CYP2D6. That is a metabolism question, not a dopamine reading, and it does not guarantee which medicine will help.12
Which symptoms need a call, and which need urgent help
Track and mention at your next visit: sleepiness, restlessness, appetite or sleep changes, nausea, dry mouth, constipation, mild dizziness, or a mild tremor. Write down when each started and how it affects your day.
Call the prescriber or pharmacist promptly: involuntary movements, severe restlessness, faintness, a persistently fast heartbeat, a major mood change, breast discharge, changes to periods or sexual function, hallucinations, manic symptoms, or significant weight change. Do not wait if something is getting worse quickly.
Call Poison Control at 1-800-222-1222 for a suspected overdose, a mix-up, or a medicine taken the wrong way. Do not wait for symptoms to start.
Call 911 now for collapse, seizure, trouble breathing, inability to wake someone, severe chest pain, or a high fever with muscle stiffness and confusion after an antipsychotic. For a suicidal or mental health crisis, call or text 988. If danger is immediate, call 911.
Stimulants carry a boxed warning for misuse, abuse, and addiction, and misuse can cause overdose and death. Store them securely and never share them. Antipsychotics carry a warning about increased death rates in older adults with dementia-related psychosis.
What to ask your prescriber
These are conversation starters, not instructions.
- Which symptom or daily function is this medicine meant to change?
- Does it block D2, partly activate it, act on a transporter, or something else?
- What improvement should we look for first, and by when?
- Which movement, prolactin, sleep, appetite, blood pressure, or heart rhythm changes matter for this specific drug?
- What should I do if I miss a dose?
- Could stopping suddenly cause withdrawal, rebound, or a return of the illness?
- How will we decide whether the benefit is worth continuing?
Bottom line
A diagnosis does not prove your dopamine was high or low. Neither does a medicine that helps.
Dopamine does several different jobs in several different places. Antipsychotics and stimulants reach different parts of that system, which is why both can be useful and why neither is a top-up or a drain. Ask what the medicine touches directly, what you should watch for, and what to do if something goes wrong. That question set will serve you better than any chemical story.
Frequently asked questions
Does schizophrenia mean dopamine is too high?
No. Group research finds higher dopamine production in specific striatal regions, on average. It does not show a whole-brain excess and cannot diagnose an individual.6
Does ADHD mean dopamine is too low?
No. Stimulants act on real targets, and they help many people. That does not mean a shortage was there first. Treatment response never proves cause.
If a stimulant changes transporters in an hour, why does progress take longer?
The molecular step is fast. Sleep, routines, skills, other conditions, and the brain’s own adaptation all move on slower clocks.
Why do two antipsychotics feel so different?
They differ in how they act at D2, what else they bind, what active byproducts they form, and how long they last. Aripiprazole partly activates D2. Lurasidone and milsaperidone block it.
Does restlessness or drowsiness mean the medicine is working?
No. Either can be an adverse effect. Judge benefit and harm separately.
Can a genetic test measure my dopamine?
No. It may inform how you process certain drugs. It cannot read dopamine in a living circuit or guarantee which medicine will work.12
Do antipsychotics drain dopamine out of the brain?
No. They act at receptors. Blocking a receptor is not the same as removing the chemical.
Related reading on NP FADY
- Your Brain Is Not a Gas Tank (start here)
- Focus, Alarm, and the Chemical Behind Both
- Rexulti (Brexpiprazole): What It Treats, Its Side Effects, and How It Compares With Abilify
- ADHD Medications Compared: Stimulants vs. Non-Stimulants for Kids and Adults
- Your DNA, Your Dose: How Genetic Testing Is Changing Psychiatric Care
References
1. Beaulieu JM, Espinoza S, Gainetdinov RR. Dopamine receptors — IUPHAR Review 13. Br J Pharmacol. 2015. PMID: 25671228
2. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011. PMID: 21303898
3. Siafis S, et al. Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects. Mol Psychiatry. 2023. PMID: 37537284
4. Berridge KC, Robinson TE. Liking, wanting, and the incentive-sensitization theory of addiction. Am Psychol. 2016. PMID: 27977239
5. Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of ADHD. Biol Psychiatry. 2011. PMID: 21550021
6. McCutcheon R, Beck K, Jauhar S, Howes OD. Defining the locus of dopaminergic dysfunction in schizophrenia. Schizophr Bull. 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC5933516/
7. Bysanti (milsaperidone) prescribing information. DailyMed. Accessed August 31, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=254a1c01-4a4c-4bdd-85d6-1f23f2e4e6f8
8. Ford CP. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience. 2014. PMID: 24463000
9. Hart XM, Schmitz CN, Gründer G. Molecular imaging of dopamine partial agonists in humans. Front Psychiatry. 2022. PMID: 35463532
10. Carbidopa and levodopa prescribing information. DailyMed. Accessed August 31, 2026. https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=9b17b028-964a-473c-823d-81423535bd66&type=pdf
11. Meiser J, Weindl D, Hiller K. Complexity of dopamine metabolism. Cell Commun Signal. 2013. PMID: 23683503
12. International Society of Psychiatric Genetics. Genetic testing statement. Accessed August 31, 2026. https://ispg.net/genetic-testing-statement/
This article is general education. It is not a diagnosis or a treatment plan. Do not start, stop, or change a medicine because of something you read here. Review every prescription, supplement, and substance with your prescriber or pharmacist.
If you or someone you know is in crisis
- Call 911 or go to your nearest emergency room for any life-threatening emergency.
- 988 Suicide & Crisis Lifeline — call or text 988, available 24/7. En español: marque 988 y oprima 2. Veterans: 988 and press 1, or text 838255.
- Crisis Text Line — text HOME to 741741.
- The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
- National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
- National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
- Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
- San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
- Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
- California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
- NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.